• Dna genomes sequencing.
    Personalized approach for Alzheimer's
    7/22/19

    UB researchers’ insights into a target that succeeded in animals but failed in humans reveal a new paradigm for screening Alzheimer’s drugs.

  • The gene FGFR1 in its natural state and the gene when exposed to laser light, which causes the gene to activate and deactivate.
    Scientists wirelessly hack ‘boss’ gene
    7/19/19

    The advancement, made possible by tiny photonic implants, could lead to new treatments for cancer and mental disorders like schizophrenia.

  • Shermain Aponte (fourth from left), a University of Puerto Rico at Cayey student, is a participant in UB’s CHEM 360° summer research program. UB chemists supporting her include (from left to right, excluding Aponte): professor Diana Aga, Aponte’s faculty research mentor; faculty members Timothy Cook and Jason Benedict, the program’s organizers; professor Luis Colón, who helped recruit Aponte to the program; and PhD student Grace Guardian, a research mentor.
    Becoming a well-rounded scientist
    7/18/19

    The Department of Chemistry’s CHEM 360° initiative offers undergrads a summer of lab work, as well as instruction on ethics and social media.

  • View of a Large Hadron Collider tunnel. ©CERN.
    Particle accelerator scientists meet in Buffalo
    7/17/19

    UB’s physics department is hosting a conference this week for researchers working with the Large Hadron Collider.

  • Aerial view of Beijing on a smoggy day.
    Air pollution linked to cardiovascular disease in China
    7/15/19

    The findings suggest that the country may need to re-evaluate its standards for nitrogen dioxide.

  • Man with face in his hands, clouds of smoke behind him.
    ‘Near miss’ linked to post-traumatic stress
    7/15/19

    A study of survivors’ near-miss experiences on 9/11 contributes to an understanding of what counts as exposure trauma.

  • Closed fist clutching three cigarettes.
    Investigating potential smoking cessation therapy
    7/11/19

    UB faculty member Jun-Xu Li has received a $2M NIH grant to look at a receptor that has recently emerged as a novel target for treating drug addiction.

  • Patient undergoing oral laser light therapy.
    Research coalition endorses light therapy
    7/11/19

    The new guidelines could offer an alternative to opioids to treat oral mucositis, the painful side effect of head and neck cancer treatment.

  • MRI images of MS patients and healthy controls that show that patients who had more than 8 scans using gadolinium-based contrast agents have areas of hyperintensity (brighter regions, white arrows) on the scans, indicating gadolinium deposition, compared to the scans of MS patients who had less than 8 scans and healthy controls.
    Gadolinium deposition occurs in early MS
    7/10/19

    A study found that while the commonly used imaging linear contrast agent does accumulate in the brain, there is no discernible clinical impact.

  • Rendering of a new administrative building for the CPNCK coffee cooperative.
    Coffee as a pathway to peace
    7/8/19

    In the Democratic Republic of the Congo, peace and economic opportunity are percolating, thanks to UB efforts to develop a more inclusive coffee value chain.

Next> <Previous